Park Place Capital’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,085
Closed -$65.6K – 690
2026
Q1
$65.6K Hold
2,085
– – 0.01% 321
2025
Q4
$61.4K Sell
2,085
-61
-3% -$1.7K 0.01% 297
2025
Q3
$54.2K Hold
2,146
– – 0.01% 318
2025
Q2
$52.1K Sell
2,146
-11
-0.5% -$255 0.01% 343
2025
Q1
$49.4K Hold
2,157
– – 0.01% 343
2024
Q4
$54.6K Sell
2,157
-151
-7% -$3.83K 0.02% 341
2024
Q3
$57.5K Sell
2,308
-455
-16% -$13.5K 0.02% 353
2024
Q2
$81.9K Sell
2,763
-2,111
-43% -$58.6K 0.03% 300
2024
Q1
$147K Sell
4,874
-2,995
-38% -$83.1K 0.05% 267
2023
Q4
$225K Sell
7,869
-398
-5% -$11.7K 0.09% 208
2023
Q3
$306K Sell
8,267
-149
-2% -$5.69K 0.09% 186
2023
Q2
$328K Sell
8,416
-496
-6% -$19.4K 0.09% 188
2023
Q1
$325K Buy
+8,912
New +$281K 0.09% 190

Other funds holding RTO

Park Place Capital's RTO Position: Q2 2026 in Review

Park Place Capital sold out of Rentokil (RTO) in Q2 2026, closing a stake of 2,085 shares — an estimated $65.6K sold.

Park Place Capital first reported a position in RTO in Q1 2023 and held it in 13 quarters. The position peaked at $328K in Q2 2023. 287 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Park Place Capital reported no remaining Rentokil position as of Q2 2026 after selling out during the quarter.
  • Park Place Capital sold 2,085 Rentokil shares in Q2 2026, an estimated $65.6K.
  • Park Place Capital first reported a position in Rentokil in Q1 2023 and held it in 13 quarters.
  • Park Place Capital's Rentokil position peaked at $328K in Q2 2023.
  • 287 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.